HIGHLIGHTS
- who: Chakravarthy Garlapati from the (UNIVERSITY) have published the research: PLK1 and AURKB phosphorylate survivin differentially to affect proliferation in racially distinct triple-negative breast cancer, in the Journal: (JOURNAL) of 30/03/2022
- what: This study provides a rationale for the development of combinatorial therapies targeting PLK1 and AURKB in AA patients with TNBC. The authors evaluated the mitotic scores in EA and AA patients with TNBC and found a higher mitotic score in TNBC tissues in AAs than in EAs (Fig 1A, B). This study provides strong evidence that TNBC disparities go beyond . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.